These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 29550643

  • 1. Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes.
    Tripathy P, Sahu A, Sahu M, Nagy A.
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():60-65. PubMed ID: 29550643
    [Abstract] [Full Text] [Related]

  • 2. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T.
    Reprod Health; 2015 Jan 16; 12():7. PubMed ID: 25595199
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
    Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX.
    BJOG; 2009 Nov 16; 116(12):1633-9. PubMed ID: 19781047
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 16; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 7. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E, Dilbaz B, Cirik DA, Ozelci R, Ozkaya E, Dilbaz S.
    J Obstet Gynaecol Res; 2016 Jul 16; 42(7):837-43. PubMed ID: 27071345
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M, Isaoglu U, Delibas IB, Kadanali S.
    J Obstet Gynaecol Res; 2011 Aug 16; 37(8):1020-6. PubMed ID: 21481088
    [Abstract] [Full Text] [Related]

  • 10. The incidence of metabolic syndrome in adolescents with different phenotypes of PCOS.
    Altintas KZ, Dilbaz B, Cirik DA, Ozelci R, Zengin T, Erginay ON, Dilbaz S.
    Ginekol Pol; 2017 Aug 16; 88(6):289-295. PubMed ID: 28727126
    [Abstract] [Full Text] [Related]

  • 11. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 16; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 12. [Polycystic ovary syndrome: is there a rise in the prevalence?].
    Carmona-Ruiz IO, Saucedo-de la Llata E, Moraga-Sánchez MR, Romeu-Sarró A.
    Ginecol Obstet Mex; 2015 Dec 16; 83(12):750-9. PubMed ID: 27290799
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R.
    J Clin Endocrinol Metab; 2006 Mar 16; 91(3):781-5. PubMed ID: 16418211
    [Abstract] [Full Text] [Related]

  • 15. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda M, Spiazzi G, Zanolin ME, Bonora E.
    J Clin Endocrinol Metab; 2013 Apr 16; 98(4):E628-37. PubMed ID: 23476073
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
    Fraissinet A, Robin G, Pigny P, Lefebvre T, Catteau-Jonard S, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1716-1722. PubMed ID: 28854589
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.
    Romualdi D, Di Florio C, Tagliaferri V, De Cicco S, Gagliano D, Immediata V, Lanzone A, Guido M.
    Reprod Sci; 2016 May 01; 23(5):655-61. PubMed ID: 26718304
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.